Direxion Daily Pharmaceutical & Medical Bull 3X Shares Rating $5.22 -0.15 (-2.79%) Closing price 04:10 PM EasternExtended Trading$5.21 -0.01 (-0.19%) As of 06:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock Direxion Daily Pharmaceutical & Medical Bull 3X Shares Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PILL Aggregate RatingModerate Buy 2.72Holdings in PILL have an aggregate rating of Moderate Buy based on 370 analyst ratings issued in the past year covering 42 companies (70.0% of the portfolio).PILL Aggregate Price Target$5.22High Prediction$5.22Average Prediction$5.22Low Prediction$5.22Holdings in PILL have an aggregate price target of $5.22 and a range of $5.22 to $5.22 covering 42 companies (70.0% of the portfolio).PILL Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy20 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily Pharmaceutical & Medical Bull 3X Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 42 PILL Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.68%ELANElanco Animal Health$14.32+0.1%2.1421 of 5 stars2.50$15.17 5.9%8News CoverageAnalyst Upgrade3.67%CORTCorcept Therapeutics$73.22-1.5%4.7304 of 5 stars3.00$138.25 88.8%5Positive NewsHigh Trading Volume2.96%RPRXRoyalty Pharma$35.87+1.7%4.8609 of 5 stars3.25$47.33 32.0%4News CoveragePositive News2.81%ZTSZoetis$156.17+0.2%4.8426 of 5 stars3.00$212.13 35.8%10Positive News2.73%LLYEli Lilly and Company$776.18-2.4%4.9713 of 5 stars2.75$1,011.61 30.3%20Trending NewsDividend Announcement2.69%PRGOPerrigo$26.55-0.1%4.8395 of 5 stars2.25$33.00 24.3%4News CoveragePositive News2.68%PBHPrestige Consumer Healthcare$81.00-0.2%4.0303 of 5 stars2.50$93.33 15.2%6High Trading Volume2.67%VTRSViatris$9.01-1.2%2.9953 of 5 stars1.80$10.40 15.4%52.64%JNJJohnson & Johnson$152.44+0.3%4.9595 of 5 stars2.55$170.88 12.1%20Positive News2.63%PFEPfizer$24.20-0.2%4.866 of 5 stars2.53$29.17 20.5%15Trending NewsDividend Announcement2.39%AXSMAxsome Therapeutics$103.36+0.8%4.6256 of 5 stars3.06$172.33 66.7%162.36%MRKMerck & Co., Inc.$78.93+0.1%4.9948 of 5 stars2.43$109.19 38.3%21Trending NewsHigh Trading Volume2.24%JAZZJazz Pharmaceuticals$106.90-0.6%4.891 of 5 stars2.92$184.00 72.1%132.24%TARSTarsus Pharmaceuticals$40.35+0.0%1.9384 of 5 stars3.00$66.67 65.2%72.22%BMYBristol Myers Squibb$46.34-0.7%4.986 of 5 stars2.32$58.00 25.2%22Positive News2.12%PCRXPacira BioSciences$23.48-1.0%3.3551 of 5 stars2.33$26.44 12.6%92.11%HRMYHarmony Biosciences$31.98+0.4%4.7735 of 5 stars3.13$53.63 67.7%8Positive NewsHigh Trading Volume1.85%OGNOrganon & Co.$9.87-1.1%4.8831 of 5 stars2.50$18.00 82.4%6Trending News1.80%AMPHAmphastar Pharmaceuticals$23.08-0.4%4.3896 of 5 stars2.25$32.33 40.1%4Positive NewsHigh Trading Volume1.62%ARVNArvinas$7.54-3.3%3.4359 of 5 stars2.55$20.29 169.1%22High Trading Volume1.57%HROWHarrow$30.88-1.5%2.655 of 5 stars3.00$61.40 98.8%6Positive News1.53%EWTXEdgewise Therapeutics$13.17+0.8%3.4421 of 5 stars2.78$39.78 202.0%9News Coverage1.51%SUPNSupernus Pharmaceuticals$31.16-0.1%2.2415 of 5 stars2.33$36.00 15.5%3High Trading Volume1.38%ANIPANI Pharmaceuticals$65.50-0.5%3.7054 of 5 stars3.00$80.13 22.3%9Positive News1.35%LGNDLigand Pharmaceuticals$114.15-1.3%4.7442 of 5 stars3.00$146.14 28.0%7Positive NewsHigh Trading Volume1.31%INVAInnoviva$19.96-2.1%4.2318 of 5 stars3.00$55.00 175.6%2Positive NewsHigh Trading Volume1.29%COLLCollegium Pharmaceutical$29.93+0.1%3.941 of 5 stars2.75$43.75 46.2%41.16%CRMDCorMedix$12.50-16.4%1.6024 of 5 stars3.17$16.67 33.3%6Trending NewsAnalyst ForecastGap DownHigh Trading Volume1.15%LQDALiquidia Technologies$13.10+2.1%3.431 of 5 stars3.00$26.89 105.3%90.95%AMRXAmneal Pharmaceuticals$8.132.9377 of 5 stars3.00$11.60 42.7%50.80%MNMDMind Medicine (MindMed)$6.55-2.8%2.4548 of 5 stars3.27$25.50 289.3%11News CoveragePositive NewsInsider Trade0.79%OCULOcular Therapeutix$9.22-2.5%3.8796 of 5 stars3.00$17.33 88.0%6High Trading Volume0.75%WVEWAVE Life Sciences$6.67-5.1%4.4058 of 5 stars2.92$20.50 207.3%12High Trading Volume0.73%EYPTEyepoint Pharmaceuticals$9.64-7.0%2.3613 of 5 stars3.00$25.67 166.3%9High Trading Volume0.59%XERSXeris Biopharma$4.70-0.8%3.8855 of 5 stars2.83$6.25 33.0%6High Trading Volume0.59%EOLSEvolus$9.14-1.8%4.0399 of 5 stars3.00$23.75 159.8%5Positive News0.51%ELVNEnliven Therapeutics$20.68-3.9%2.2389 of 5 stars3.00$39.60 91.5%5Insider TradeHigh Trading Volume0.47%NUVBNuvation Bio$1.94-1.4%3.5487 of 5 stars3.20$7.17 269.0%5Analyst ForecastHigh Trading Volume0.45%PAHCPhibro Animal Health$25.66+2.1%3.5135 of 5 stars1.67$21.80 -15.0%6Analyst ForecastHigh Trading Volume0.39%ZVRAZevra Therapeutics$9.00-3.0%3.095 of 5 stars3.11$22.29 147.6%9Positive NewsHigh Trading Volume0.38%ESPREsperion Therapeutics$0.99-2.6%4.1213 of 5 stars2.80$7.00 604.5%50.24%OMEROmeros$3.20-3.6%3.7835 of 5 stars2.83$18.00 462.5%6News CoveragePositive NewsHigh Trading Volume This page (NYSEARCA:PILL) was last updated on 6/27/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily Pharmaceutical & Medical Bull 3X Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily Pharmaceutical & Medical Bull 3X Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
